Arcus Biosciences, Inc. 10-Q

Item 5. Other Information. None. 57 Item 6. E xhibits. Exhibit Number Exhibit Description Incorporated by Reference Form File No. Exhibit Filing Date 3.1 Amended and Restated Certificate of Incorporation 10-Q 001-38419 3.1 May 9, 2018 3.2 Amended and Restated Bylaws 8-K 001-38419 3.1 May 26, 2020 10.1 Separation and Consulting Agreement by and between the Company and William Grossman dated July 16, 2021. 10-Q 001-38419 10.3 August 5, 2021 31.1 * Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 * Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1† Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2† Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in exhibit 101) * Filed herewith. † This certification is deemed furnished but not filed for purposes of section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act. 58 SIGNA TURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ARCUS BIOSCIENCES, INC. Date: November 8, 2021 By: /s/ Terry Rosen Terry Rosen, Ph.D. Chief Executive Officer (Principal Executive Officer) Date: November 8, 2021 By: /s/ Robert C. Goeltz II Robert C. Goeltz II Chief Financial Officer (Principal Financial and Accounting Officer) 59